A four‐factor immune risk score signature predicts the clinical outcome of patients with spinal chordoma

BACKGROUND: Currently, the measurement of immune cells in previous studies is usually subjective, and no immune‐based prognostic model has been established for chordoma. In this study, we sought to simultaneously measure tumor‐infiltrating lymphocyte (TIL) subtypes in chordoma samples using an objec...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Ming‐Xiang, Pan, Yue, Huang, Wei, Zhang, Tao‐Lan, Escobar, David, Wang, Xiao‐Bin, Jiang, Yi, She, Xiao‐Ling, Lv, Guo‐Hua, Li, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240847/
https://www.ncbi.nlm.nih.gov/pubmed/32508056
http://dx.doi.org/10.1002/ctm2.4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240847/
https://www.ncbi.nlm.nih.gov/pubmed/32508056
http://dx.doi.org/10.1002/ctm2.4

Ejemplares similares